Details for Patent: 9,861,630
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,861,630 protect, and when does it expire?
Patent 9,861,630 protects TRINTELLIX and is included in one NDA.
This patent has eighty-nine patent family members in thirty-three countries.
Summary for Patent: 9,861,630
Title: | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT.sub.3 and 5-HT.sub.1A activity for the treatment of cognitive impairment |
Abstract: | 1-[2-(2,4-dimethylphenylsulphanyl)phenyl)]piperazine exhibits potent activity on SERT, 5-HT.sub.3 and 5-HT.sub.1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients. |
Inventor(s): | Faldt; Andre (Ishoj, DK), Lopez de Diego; Heidi (N.ae butted.rum, DK), Holm; Rene (Jyllinge, DK) |
Assignee: | H. Lundbeck A/S (Valby, DK) |
Application Number: | 15/674,043 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,861,630 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,861,630
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | TRINTELLIX | vortioxetine hydrobromide | TABLET;ORAL | 204447-001 | Sep 30, 2013 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | METHOD OF TREATING DEPRESSION OR MAJOR DEPRESSIVE DISORDER | See Plans and Pricing | ||||
Takeda Pharms Usa | TRINTELLIX | vortioxetine hydrobromide | TABLET;ORAL | 204447-002 | Sep 30, 2013 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | METHOD OF TREATING DEPRESSION OR MAJOR DEPRESSIVE DISORDER | See Plans and Pricing | ||||
Takeda Pharms Usa | TRINTELLIX | vortioxetine hydrobromide | TABLET;ORAL | 204447-003 | Sep 30, 2013 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | METHOD OF TREATING DEPRESSION OR MAJOR DEPRESSIVE DISORDER | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,861,630
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Denmark | 2006 00824 | Jun 16, 2006 |
Denmark | 2006 01223 | Sep 22, 2006 |
Denmark | 2006 01384 | Oct 25, 2006 |
International Family Members for US Patent 9,861,630
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 061481 | See Plans and Pricing | |||
Argentina | 065797 | See Plans and Pricing | |||
Austria | 495745 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |